The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season
Open accessAbstract
This report updates the 2016-17 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines (MMWR Recomm Rep 2016;65[No. RR-5]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. A licensed, recommended, and age-appropriate vaccine should be used.For the 2017-18 season, quadrivalent and trivalent influenza vaccines will be available. Inactivated influenza vaccines (IIVs) will be available in trivalent (IIV3) and quadrivalent (IIV4) formulations. Recombinant influenza vaccine (RIV) will be available in trivalent (RIV3) and quadrivalent (RIV4) formulations. Live attenuated influenza vaccine (LAIV4) is not recommended for use during the 2017-18 season due to concerns about its effectiveness against (H1N1)pdm09 viruses during the 2013-14 and 2015-16 seasons. Recommendations for different vaccine types and specific populations are discussed. No preferential recommendation is made for one influenza vaccine product over another for persons for whom more than one licensed, recommended product is available.Updates to the recommendations described in this report reflect discussions during public meetings of ACIP held on October 20, 2016; February 22, 2017; and June 21, 2017. New and updated information in this report includes the following:•Vaccine viruses included in the 2017-18 U.S. trivalent influenza vaccines will be an A/Michigan/45/2015 (H1N1)pdm09-like virus, an A/Hong Kong/4801/2014 (H3N2)-like virus, and a B/Brisbane/60/2008-like virus (Victoria lineage). Quadrivalent influenza vaccines will contain these three viruses and an additional influenza B vaccine virus, a B/Phuket/3073/2013-like virus (Yamagata lineage).• Information on recent licensures and labelling changes is discussed, including licensure of Afluria Quadrivalent (IIV4; Seqirus, Parkville, Victoria, Australia); Flublok Quadrivalent (RIV4; Protein Sciences, Meriden, Connecticut); and expansion of the age indication for FluLaval Quadrivalent (IIV4; ID Biomedical Corporation of Quebec, Quebec City, Quebec, Canada), previously licensed for ≥3 years, to ≥6 months.• Pregnant women may receive any licensed, recommended, age-appropriate influenza vaccine.• Afluria (IIV3; Seqirus, Parkville, Victoria, Australia) may be used for persons aged ≥5 years, consistent with Food and Drug Administration-approved labeling.• FluMist Quadrivalent (LAIV4; MedImmune, Gaithersburg, Maryland) should not be used during the 2017-18 season due to concerns about its effectiveness against influenza A(H1N1)pdm09 viruses in the United States during the 2013-14 and 2015-16 influenza seasons.This report focuses on the recommendations for use of vaccines for the prevention and control of influenza during the 2017-18 season in the United States. A Background Document containing further information and a summary of these recommendations are available at https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/flu.html. These recommendations apply to licensed influenza vaccines used within Food and Drug Administration-licensed indications, including those licensed after the publication date of this report. Updates and other information are available at CDC's influenza website (https://www.cdc.gov/flu). Vaccination and health care providers should check CDC's influenza website periodically for additional information.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fiore, A. E., Uyeki, T. M., Broder, K. R., Finelli, L., Euler, G. L., Singleton, J. A., Iskander, J. K., Wortley, P. M., Shay, D. K., Bresee, J., et al. (2009) · PubMed · Cited by 2,077
Self-citation2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit816 · Cited by 1,037
Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States
Siston, A. M. (2010) · JAMA · doi:10.1001/jama.2010.479 · Cited by 1,034
(2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03793.x · Cited by 957
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
DiazGranados, C. A., Dunning, A. J., Kimmel, M., Kirby, D., Treanor, J., Collins, A., Pollak, R., Christoff, J., Earl, J., Landolfi, V., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315727 · Cited by 876 · cited 1×
“HD-IIV3 exhibited superior efficacy over a comparator standard-dose IIV3 for adults aged ≥65 years in a large (N = 31,989), two-season randomized, controlled, double-blind trial (43,44), and might provide better protection than SD-IIV3s for this age group.”
BackgroundThe Underrecognized Burden of Influenza in Young Children
Poehling, K. A., Edwards, K. M., Weinberg, G. A., Szilagyi, P., Staat, M. A., Iwane, M. K., Bridges, C. B., Grijalva, C. G., Zhu, Y., Bernstein, D. I., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054869 · Cited by 872
Shefer, A. M., & Atkinson, W. W. (2011) · Cited by 665
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Olsen, S. J., Karron, R. A., Jernigan, D. B., & Bresee, J. S. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6505a1 · Cited by 593
Self-citationPearson, M. L., Bridges, C. B., & Harper, S. A. (2006) · PsycEXTRA Dataset · doi:10.1037/e506932006-001 · Cited by 529
(2011) · PubMed · Cited by 424
IMPACT OF EPIDEMIC TYPE A INFLUENZA IN A DEFINED ADULT POPULATION
BARKER, W. H., & MULLOOLY, J. P. (1980) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113052 · Cited by 370
Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older
Dunkle, L. M., Izikson, R., Patriarca, P., Goldenthal, K. L., Muse, D., Callahan, J., & Cox, M. M. J. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608862 · Cited by 291
Barker, W. H. (1986) · American Journal of Public Health · doi:10.2105/ajph.76.7.761 · Cited by 290
Influenza- and RSV-associated hospitalizations among adults
Mullooly, J. P., Bridges, C. B., Thompson, W. W., Chen, J., Weintraub, E., Jackson, L. A., Black, S., & Shay, D. K. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.09.041 · Cited by 235
Kissling, E., Valenciano, M., Larrauri, A., Oroszi, B., Cohen, J. M., Nunes, B., Pitigoi, D., Rizzo, C., Rebolledo, J., Paradowska-Stankiewicz, I., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.05.20390-en · Cited by 195
Ferdinands, J. M., Fry, A. M., Reynolds, S., Petrie, J. G., Flannery, B., Jackson, M. L., & Belongia, E. A. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw816 · Cited by 195
Self-citationNeuzil, K. M., Jackson, L. A., Nelson, J., Klimov, A., Cox, N., Bridges, C. B., Dunn, J., DeStefano, F., & Shay, D. (2006) · The Journal of Infectious Diseases · doi:10.1086/507309 · Cited by 191
Ritzwoller, D. P., Bridges, C. B., Shetterly, S., Yamasaki, K., Kolczak, M., & France, E. K. (2005) · Pediatrics · doi:10.1542/peds.2005-0049 · Cited by 182
Rapid Decline of Influenza Vaccine–Induced Antibody in the Elderly: Is It Real, or Is It Relevant?
Skowronski, D. M., Tweed, S. A., & De Serres, G. (2008) · The Journal of Infectious Diseases · doi:10.1086/524146 · Cited by 173
Pebody, R. G., Andrews, N., McMenamin, J., Durnall, H., Ellis, J., Thompson, C. I., Robertson, C., Cottrell, S., Smyth, B., Zambon, M., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.05.20389-en · Cited by 163
Van Buynder, P. G., Konrad, S., Van Buynder, J. L., Brodkin, E., Krajden, M., Ramler, G., & Bigham, M. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.059 · Cited by 160
Belongia, E. A., Sundaram, M. E., McClure, D. L., Meece, J. K., Ferdinands, J. M., & VanWormer, J. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.06.052 · Cited by 152
Song, J. Y., Cheong, H. J., Hwang, I. S., Choi, W. S., Jo, Y. M., Park, D. W., Cho, G. J., Hwang, T. G., & Kim, W. J. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.03.067 · Cited by 147
Cruise Ships: High-Risk Passengers and the Global Spread of New Influenza Viruses
Miller, J. M., Tam, T. W. S., Maloney, S. A., Fukuda, K., Cox, N., Hockin, J., Kertesz, D. A., Klimov, A. I., & Cetron, M. S. (2000) · Clinical Infectious Diseases · doi:10.1086/313974 · Cited by 137
Influenza Virus Infection in Travelers to Tropical and Subtropical Countries
Mütsch, M., Tavernini, M., Marx, A., Gregory, V., Lin, Y. P., Hay, A. J., Tschopp, A., & Steffen, R. J. (2005) · Clinical Infectious Diseases · doi:10.1086/429243 · Cited by 136
Eisenberg, K. W., Szilagyi, P. G., Fairbrother, G., Griffin, M. R., Staat, M. A., Shone, L. P., Weinberg, G. A., Hall, C. B., Poehling, K. A., Edwards, K. M., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2007-3304 · Cited by 133
Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season
Allison, M. A., Daley, M. F., Crane, L. A., Barrow, J. C., Beaty, B. L., Allred, N. J., Berman, S., & Kempe, A. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.06.036 · Cited by 130
DiazGranados, C. A., Dunning, A. J., Jordanov, E., Landolfi, V. A., Denis, M., & Talbot, H. K. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.12.013 · Cited by 127
Petrie, J. G., Ohmit, S. E., Johnson, E., Truscon, R., & Monto, A. S. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv313 · Cited by 126
DiazGranados, C. A., Robertson, C. A., Talbot, H. K., Landolfi, V. A., Dunning, A. J., & Greenberg, D. P. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.006 · Cited by 125
Sukumaran, L., McCarthy, N. L., Kharbanda, E. O., Weintraub, E., Vazquez‐Benitez, G., McNeil, M. M., Li, R., Klein, N. P., Hambidge, S. J., Naleway, A. L., et al. (2015) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001066 · Cited by 117
Künzel, W., Glathe, H., Engelmann, H., & Hoecke, C. V. (1996) · Vaccine · doi:10.1016/0264-410x(96)00061-8 · Cited by 97
Kerzner, B., Murray, A. V., Cheng, E., Ifle, R., Harvey, P. R., Tomlinson, M., Barben, J. L., Rarrick, K., Stek, J. E., Chung, M., et al. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01397.x · Cited by 96
DiazGranados, C. A., Dunning, A. J., Robertson, C. A., Talbot, H. K., Landolfi, V. A., & Greenberg, D. P. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.003 · Cited by 94
Schwarz, T. F., Flamaing, J., Rümke, H. C., Penzes, J., Juergens, C., Wenz, A., Jayawardene, D., Giardina, P., Emini, E. A., Gruber, W. C., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.031 · Cited by 94
Febrile Seizure Risk After Vaccination in Children 6 to 23 Months
Duffy, J., Weintraub, E., Hambidge, S. J., Jackson, L. A., Kharbanda, E. O., Klein, N. P., Lee, G. M., Marcy, S. M., Nakasato, C. C., Naleway, A. L., et al. (2016) · PEDIATRICS · doi:10.1542/peds.2016-0320 · Cited by 88
Large Summertime Influenza A Outbreak among Tourists in Alaska and the Yukon Territory
Uyeki, T. M., Zane, S. B., Bodnar, U. R., Fielding, K., Buxton, J. A., Miller, J. M., Beller, M. J., Butler, J. C., Fukuda, K., Maloney, S. A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374053 · Cited by 76
Fowlkes, A., Steffens, A., Temte, J., Lonardo, S. S. D., McHugh, L., Martin, K., Rubino, H., Feist, M. A., Davis, C., Selzer, C., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00278-7 · Cited by 74
Frenck, R. W., Gurtman, A., Rubino, J., Smith, W., van Cleeff, M., Jayawardene, D. A., Giardina, P. C., Emini, E. A., Gruber, W. C., Scott, D. A., et al. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00176-12 · Cited by 73
Randomized Controlled Trial of Dose Response to Influenza Vaccine in Children Aged 6 to 23 Months
Skowronski, D. M., Salway, T. J., Chong, M., Serres, G. D., Scheifele, D. W., Ward, B. J., Halperin, S. A., Janjua, N. Z., Chan, T., Sabaiduc, S., et al. (2011) · PEDIATRICS · doi:10.1542/peds.2010-2777 · Cited by 73
Lum, L. C. S., Borja-Tabora, C., Breiman, R. F., Vesikari, T., Sablan, B. P., Chay, O. M., Tantracheewathorn, T., Schmitt, H.-J., Lau, Y., Bowonkiratikachorn, P., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.11.054 · Cited by 70
Recommendations for the administration of influenza vaccine in children allergic to egg
Erlewyn‐Lajeunesse, M., Brathwaite, N., Lucas, J. S., & Warner, J. O. (2009) · BMJ · doi:10.1136/bmj.b3680 · Cited by 67
Stockwell, M. S., Broder, K. R., LaRussa, P. S., Lewis, P., Fernandez, N., Sharma, D., Barrett, A. E., Sosa, J., & Vellozzi, C. J. (2014) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2013.4469 · Cited by 57
Self-citationNolan, T. M., Bernstein, D. I., Block, S. L., Hilty, M. D., KEYSERLING, H. L., Marchant, C. D., Marshall, H. S., Richmond, P., Yogev, R., Cordova, J. M., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2007-1064 · Cited by 49
Li, R., Stewart, B., McNeil, M. M., Duffy, J., Nelson, J. C., Kawai, A. T., Baxter, R. P., Belongia, E. A., & Weintraub, E. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3996 · Cited by 45
Ratnam, I., Black, J., Leder, K. S., Biggs, B., Gordon, I., Matchett, E., Padiglione, A. A., Woolley, I. J., Karapanagiotidis, T., Gherardin, T., et al. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.01.008 · Cited by 40
Jain, V. K., Domachowske, J. B., Wang, L., Ofori‐Anyinam, O., Weber, M., Leonardi, M. L., Klein, N. P., Schlichter, G., Jeanfreau, R. J., Haney, B. L., et al. (2016) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piw068 · Cited by 35
Treanor, J. J., Albano, F. R., Sawlwin, D. C., Jones, A. G., Airey, J., Formica, N. T., Matassa, V., & Leong, J. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.02.066 · Cited by 35
Song, J. Y., Cheong, H. J., Tsai, T. F., Chang, H.-A., Choi, M. J., Jeon, J. H., Kang, S. H., Jeong, E. J., Noh, J. Y., & Kim, W. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.003 · Cited by 34
Breiman, R. F., Brooks, W. A., Goswami, D. R., Lagos, R., Borja-Tabora, C., Lanata, C. F., Londoño, J. A. C., Lum, L. C. S., Rappaport, R., Razmpour, A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.002 · Cited by 32
McNeil, S., Noya, F., Dionne, M., Predy, G., Meekison, W., Ojah, C., Ferro, S., Mills, E. L., Langley, J. M., & Halperin, S. A. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.12.047 · Cited by 31
Cited by
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,632
Self-citationEffects of Influenza Vaccination in the United States During the 2017–2018 Influenza Season
Rolfes, M. A., Flannery, B., Chung, J. R., O’Halloran, A., Garg, S., Belongia, E. A., Gaglani, M., Zimmerman, R. K., Jackson, M. L., Monto, A. S., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz075 · Cited by 297
Self-citationVaccine-associated hypersensitivity
McNeil, M. M., & DeStefano, F. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.12.971 · Cited by 273
Racial/Ethnic Disparities in Influenza Vaccination Coverage Among US Adolescents, 2010-2016
Webb, N. S., Dowd-Arrow, B., Taylor, M. G., & Burdette, A. M. (2018) · Public Health Reports® · doi:10.1177/0033354918805720 · Cited by 26
Metadata
- Authors
- Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Bresee, J. S., Fry, A. M., & Jernigan, D. B.
- Venue
- MMWR. Recommendations and Reports
- Published
- 2017-08-25
- Volume
- 66
- Issue
- 2
- Pages
- 1-20
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- OpenAlex
- W4229810677
- Cited by
- 387
- References
- 52
- FWCI
- 52.12
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.